Recent Updates
Recently added Catalysts
APYX Positive Sentiment Score: 65/100

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

Tuesday, November 12, 2024 2 min read
Key Takeaway: Apyx Medical Corporation, known for its Renuvion helium plasma and radiofrequency platform technology, is set to attend the 15th Annual Craig-Hallum Alpha Select Conference. The event will take place on November 19, 2024, in New York City, where CEO Charles Goodwin and CFO Matt Hill will hold 1x1 meetings with investors. The company emphasizes its innovative products in the cosmetic and hospital surgical markets and invites interested parties to schedule meetings through their representatives.

Market Sentiment Analysis

POSITIVE FACTORS

  • Apyx Medical is showcasing its participation in a significant conference, highlighting its commitment to engaging with investors.
  • The company's Renuvion technology is backed by over 90 clinical documents, indicating strong clinical support.
  • Engagement in 1x1 meetings at the conference suggests potential positive interactions with interested investors.

Full Press Release Details

CLEARWATER, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that Charles Goodwin, President and CEO and Matt Hill, CFO will be attending the following upcoming conference:
Event: 15th Annual Craig-Hallum Alpha Select Conference
Date: November 19, 2024
Location: Sheraton NY Times Square Hotel, New York, NY
Format: 1x1 Meetings
To request a meeting with Apyx, investors should contact their Craig Hallum representative.
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.
Investor Relations Contact:
Jeremy Feffer, Managing Director LifeSci Advisors
jfeffer@lifesciadvisors.com

Frequently Asked Questions

What is Renuvion® by Apyx Medical?

Renuvion® is a proprietary helium plasma and radiofrequency platform technology.

When is the 15th Annual Craig-Hallum Conference?

The conference is scheduled for November 19, 2024.

Where will the Craig-Hallum Conference be held?

It will take place at the Sheraton NY Times Square Hotel, New York, NY.

How can investors meet with Apyx Medical at the conference?

Investors should contact their Craig Hallum representative to request a meeting.

What technologies do Renuvion and J-Plasma use?

They use controlled heat to tissue for achieving surgical results.

Tags: APYX Viatris Investor Conferences Healthcare Apyx Medical Renuvion Craig-Hallum alpha select conference investor relations
Last updated: Nov 12, 2024